ParkinsonCanadaV1, Main, Exploration, bibRecord, 003E86

Risk factors for peak dose dyskinesia in 100 levodopa-treated parkinsonian patients

Identifieur interne : 003E86 ( Main/Exploration ); précédent : 003E85; suivant : 003E87

Risk factors for peak dose dyskinesia in 100 levodopa-treated parkinsonian patients

Auteurs : P. J. Blanchet [Canada] ; P. Allard [Canada] ; L. Gregoire [Canada] ; F. Tardif [Canada] ; P. J. Bedard [Canada]

Source :

Canadian journal of neurological sciences [ 0317-1671 ] ; 1996.

RBID : Pascal:96-0416688

Descripteurs français

Pascal (Inist)
- Parkinson maladie, Dyskinésie, Lévodopa, Antiparkinsonien, Aminoacide, Chimiothérapie, Facteur risque, Homme, Rétrospective, Agoniste, Récepteur dopaminergique.
Wicri :
- topic : Homme.

English descriptors

KwdEn :
- Adult, Aged, Agonist, Aminoacid, Antiparkinson agent, Chemotherapy, Dopamine receptor, Dyskinesia, Female, Human, Humans, Levodopa, Levodopa (administration & dosage), Levodopa (adverse effects), Male, Middle Aged, Movement Disorders (drug therapy), Parkinson Disease (drug therapy), Parkinson disease, Retrospective, Retrospective Studies, Risk Factors, Risk factor, Time Factors.
MESH :
- chemical , administration & dosage : Levodopa.
- chemical , adverse effects : Levodopa.
- drug therapy : Movement Disorders, Parkinson Disease.
- Adult, Aged, Female, Humans, Male, Middle Aged, Retrospective Studies, Risk Factors, Time Factors.

Affiliations:

Canada

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Risk factors for peak dose dyskinesia in 100 levodopa-treated parkinsonian patients</title>
<author><name sortKey="Blanchet, P J" sort="Blanchet, P J" uniqKey="Blanchet P" first="P. J." last="Blanchet">P. J. Blanchet</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Neurobiology Research Centre, Hôpital de l'Enfant-Jésus</s1>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Neurobiology Research Centre, Hôpital de l'Enfant-Jésus</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Allard, P" sort="Allard, P" uniqKey="Allard P" first="P." last="Allard">P. Allard</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Epidemiology Research Unit, Hôpital du Saint-Sacrement</s1>
<s2>Québec City (Québec)</s2>
<s3>CAN</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Québec City (Québec)</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Gregoire, L" sort="Gregoire, L" uniqKey="Gregoire L" first="L." last="Gregoire">L. Gregoire</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Neurobiology Research Centre, Hôpital de l'Enfant-Jésus</s1>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Neurobiology Research Centre, Hôpital de l'Enfant-Jésus</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Tardif, F" sort="Tardif, F" uniqKey="Tardif F" first="F." last="Tardif">F. Tardif</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Neurobiology Research Centre, Hôpital de l'Enfant-Jésus</s1>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Neurobiology Research Centre, Hôpital de l'Enfant-Jésus</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Bedard, P J" sort="Bedard, P J" uniqKey="Bedard P" first="P. J." last="Bedard">P. J. Bedard</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Neurobiology Research Centre, Hôpital de l'Enfant-Jésus</s1>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Neurobiology Research Centre, Hôpital de l'Enfant-Jésus</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">96-0416688</idno>
<date when="1996">1996</date>
<idno type="stanalyst">PASCAL 96-0416688 INIST</idno>
<idno type="RBID">Pascal:96-0416688</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000F26</idno>
<idno type="wicri:Area/PascalFrancis/Curation">000F97</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">000E11</idno>
<idno type="wicri:explorRef" wicri:stream="PascalFrancis" wicri:step="Checkpoint">000E11</idno>
<idno type="wicri:doubleKey">0317-1671:1996:Blanchet P:risk:factors:for</idno>
<idno type="wicri:Area/Main/Merge">004577</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:8862840</idno>
<idno type="wicri:Area/PubMed/Corpus">001867</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001867</idno>
<idno type="wicri:Area/PubMed/Curation">001867</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001867</idno>
<idno type="wicri:Area/PubMed/Checkpoint">001867</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001867</idno>
<idno type="wicri:Area/Ncbi/Merge">002551</idno>
<idno type="wicri:Area/Ncbi/Curation">002551</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">002551</idno>
<idno type="wicri:doubleKey">0317-1671:1996:Blanchet P:risk:factors:for</idno>
<idno type="wicri:Area/Main/Merge">004348</idno>
<idno type="wicri:Area/Main/Curation">003E86</idno>
<idno type="wicri:Area/Main/Exploration">003E86</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Risk factors for peak dose dyskinesia in 100 levodopa-treated parkinsonian patients</title>
<author><name sortKey="Blanchet, P J" sort="Blanchet, P J" uniqKey="Blanchet P" first="P. J." last="Blanchet">P. J. Blanchet</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Neurobiology Research Centre, Hôpital de l'Enfant-Jésus</s1>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Neurobiology Research Centre, Hôpital de l'Enfant-Jésus</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Allard, P" sort="Allard, P" uniqKey="Allard P" first="P." last="Allard">P. Allard</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Epidemiology Research Unit, Hôpital du Saint-Sacrement</s1>
<s2>Québec City (Québec)</s2>
<s3>CAN</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Québec City (Québec)</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Gregoire, L" sort="Gregoire, L" uniqKey="Gregoire L" first="L." last="Gregoire">L. Gregoire</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Neurobiology Research Centre, Hôpital de l'Enfant-Jésus</s1>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Neurobiology Research Centre, Hôpital de l'Enfant-Jésus</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Tardif, F" sort="Tardif, F" uniqKey="Tardif F" first="F." last="Tardif">F. Tardif</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Neurobiology Research Centre, Hôpital de l'Enfant-Jésus</s1>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Neurobiology Research Centre, Hôpital de l'Enfant-Jésus</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Bedard, P J" sort="Bedard, P J" uniqKey="Bedard P" first="P. J." last="Bedard">P. J. Bedard</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Neurobiology Research Centre, Hôpital de l'Enfant-Jésus</s1>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Neurobiology Research Centre, Hôpital de l'Enfant-Jésus</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Canadian journal of neurological sciences</title>
<title level="j" type="abbreviated">Can. j. neurol. sci.</title>
<idno type="ISSN">0317-1671</idno>
<imprint><date when="1996">1996</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Canadian journal of neurological sciences</title>
<title level="j" type="abbreviated">Can. j. neurol. sci.</title>
<idno type="ISSN">0317-1671</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term>
<term>Aged</term>
<term>Agonist</term>
<term>Aminoacid</term>
<term>Antiparkinson agent</term>
<term>Chemotherapy</term>
<term>Dopamine receptor</term>
<term>Dyskinesia</term>
<term>Female</term>
<term>Human</term>
<term>Humans</term>
<term>Levodopa</term>
<term>Levodopa (administration & dosage)</term>
<term>Levodopa (adverse effects)</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Movement Disorders (drug therapy)</term>
<term>Parkinson Disease (drug therapy)</term>
<term>Parkinson disease</term>
<term>Retrospective</term>
<term>Retrospective Studies</term>
<term>Risk Factors</term>
<term>Risk factor</term>
<term>Time Factors</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Levodopa</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Levodopa</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Movement Disorders</term>
<term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adult</term>
<term>Aged</term>
<term>Female</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Retrospective Studies</term>
<term>Risk Factors</term>
<term>Time Factors</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Parkinson maladie</term>
<term>Dyskinésie</term>
<term>Lévodopa</term>
<term>Antiparkinsonien</term>
<term>Aminoacide</term>
<term>Chimiothérapie</term>
<term>Facteur risque</term>
<term>Homme</term>
<term>Rétrospective</term>
<term>Agoniste</term>
<term>Récepteur dopaminergique</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Homme</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<affiliations><list><country><li>Canada</li>
</country>
</list>
<tree><country name="Canada"><noRegion><name sortKey="Blanchet, P J" sort="Blanchet, P J" uniqKey="Blanchet P" first="P. J." last="Blanchet">P. J. Blanchet</name>
</noRegion>
<name sortKey="Allard, P" sort="Allard, P" uniqKey="Allard P" first="P." last="Allard">P. Allard</name>
<name sortKey="Bedard, P J" sort="Bedard, P J" uniqKey="Bedard P" first="P. J." last="Bedard">P. J. Bedard</name>
<name sortKey="Gregoire, L" sort="Gregoire, L" uniqKey="Gregoire L" first="L." last="Gregoire">L. Gregoire</name>
<name sortKey="Tardif, F" sort="Tardif, F" uniqKey="Tardif F" first="F." last="Tardif">F. Tardif</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003E86 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 003E86 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     Pascal:96-0416688
   |texte=   Risk factors for peak dose dyskinesia in 100 levodopa-treated parkinsonian patients
}}

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022

La maladie de Parkinson au Canada (serveur d'exploration)

Risk factors for peak dose dyskinesia in 100 levodopa-treated parkinsonian patients

Risk factors for peak dose dyskinesia in 100 levodopa-treated parkinsonian patients

Source :

Descripteurs français

English descriptors

Links toward previous steps (curation, corpus...)

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

	La maladie de Parkinson au Canada (serveur d'exploration)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.